These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9118562)

  • 21. Genetic susceptibility to atherosclerosis.
    Chamberlain JC; Galton DJ
    Br Med Bull; 1990 Oct; 46(4):917-40. PubMed ID: 1983134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein genes and hyperlipidemia.
    Baralle FE; Shoulders CC
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1351-8. PubMed ID: 6494870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary artery disease, lipid disorders and genetic polymorphisms.
    Ordovas JM; Schaefer EJ
    Ann Biol Clin (Paris); 1988; 46(1):24-9. PubMed ID: 2898907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms and atherosclerosis.
    Galton DJ
    Monogr Atheroscler; 1986; 14():113-8. PubMed ID: 3090427
    [No Abstract]   [Full Text] [Related]  

  • 25. The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease.
    Contois JH; Anamani DE; Tsongalis GJ
    Clin Lab Med; 1996 Mar; 16(1):105-23. PubMed ID: 8867586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common genetic determinants of dyslipidemia: the hypertriglyceridemia/low-high-density lipoprotein syndrome.
    Galton DJ
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S35-40. PubMed ID: 8907213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The genetic bases of the lipid metabolic disorders in atherosclerosis].
    Tselĭko VI
    Tsitol Genet; 1996; 30(2):74-82. PubMed ID: 9281205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA polymorphisms at the lipoprotein lipase gene and their association with quantitative variation in plasma high-density lipoproteins and triacylglycerides.
    Mitchell RJ; Earl L; Bray P; Fripp YJ; Williams J
    Hum Biol; 1994 Jun; 66(3):383-97. PubMed ID: 8026810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic predisposition to hyperlipidaemia in diabetes: the end of the beginning?
    Wilson DE; Kwong LK; Elbein SC; Lalouel JM
    J Intern Med Suppl; 1994; 736():53-61. PubMed ID: 7986310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
    Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
    Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of genetic principles to the causal assessment of atherosclerosis].
    Miserez AR; Braun JR
    Ther Umsch; 1995 Dec; 52(12):835-43. PubMed ID: 8539656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [LPL gene polymorphism].
    Kobayashi J
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():790-4. PubMed ID: 11347175
    [No Abstract]   [Full Text] [Related]  

  • 33. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    Am Heart J; 2004 Jun; 147(6):1117-24. PubMed ID: 15199365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of coronary heart disease and its risk factors.
    Berg K
    Prog Clin Biol Res; 1985; 177():351-74. PubMed ID: 3160046
    [No Abstract]   [Full Text] [Related]  

  • 36. [Molecular biology of apolipoproteins in genesis of hyperlipidemias and atherosclerosis].
    Hata Y
    Nihon Rinsho; 1993 Jun; 51(6):1668-76. PubMed ID: 8320847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency.
    Marçais C; Bernard S; Merlin M; Ulhmann M; Mestre B; Rochet-Mingret L; Revol A; Berthezene F; Moulin P
    Diabetologia; 2000 Nov; 43(11):1346-52. PubMed ID: 11126401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relations of lipoprotein lipase gene polymorphism at Pvu II locus and dietary intervention predisposition in hyperlipidemia population].
    Zhu W; Zhang Z; Wang J; Qi Z
    Wei Sheng Yan Jiu; 2003 Mar; 32(2):147-9, 158. PubMed ID: 12793009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA polymorphism and the study of disease associations.
    Cooper DN; Clayton JF
    Hum Genet; 1988 Apr; 78(4):299-312. PubMed ID: 2896152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study.
    Marshall HW; Morrison LC; Wu LL; Anderson JL; Corneli PS; Stauffer DM; Allen A; Karagounis LA; Ward RH
    Circulation; 1994 Feb; 89(2):567-77. PubMed ID: 8313545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.